{"id":45761,"date":"2022-07-01T19:01:48","date_gmt":"2022-07-01T17:01:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/2022-good-documentation-practices-webinar-look-at-documentation-practices-that-should-be-avoided-researchandmarkets-com\/"},"modified":"2022-07-01T19:01:48","modified_gmt":"2022-07-01T17:01:48","slug":"2022-good-documentation-practices-webinar-look-at-documentation-practices-that-should-be-avoided-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/2022-good-documentation-practices-webinar-look-at-documentation-practices-that-should-be-avoided-researchandmarkets-com\/","title":{"rendered":"2022 Good Documentation Practices Webinar – Look at Documentation Practices That Should be Avoided – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Good Documentation Practices”<\/a> webinar has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\n“Good Documentation Practices” is a “current” industry practice that is reviewed and cited by federal regulators when audited. Pharmaceutical\/Biological documents are legal documents that are controlled by all regulatory agencies.\n<\/p>\n

\nThe person or persons responsible for filling out these documents accepts the consequences if the documents are not filled out according to good documentation practices.\n<\/p>\n

\nGood documentation practices are expected to assure they are accurate, legible and traceable to name a few. The lack of such good documentation practices is routinely cited in FDA 483 observations.\n<\/p>\n

\nThis webinar will cover the basics of what good documentation practices include, along with examples of practices not acceptable to auditors.\n<\/p>\n

\nThe webinar will help attendees review their own procedures and what should be included in applicable training sessions for new employees along with refresher training for those who are more experienced.\n<\/p>\n

\nWho Should Attend:<\/strong>\n<\/p>\n